IDRSF (Idorsia) Marketable Securities : $20.2 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Idorsia Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Idorsia's Marketable Securities for the quarter that ended in Dec. 2024 was $20.2 Mil.

Idorsia's annual Marketable Securities declined from Dec. 2022 ($354.6 Mil) to Dec. 2023 ($14.8 Mil) but then increased from Dec. 2023 ($14.8 Mil) to Dec. 2024 ($20.2 Mil).

Idorsia Marketable Securities Historical Data

The historical data trend for Idorsia's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Idorsia Marketable Securities Chart

Idorsia Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

978.41

1,017.13

354.58

14.76

20.17

Idorsia Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Marketable Securities	Get a 7-Day Free Trial															14.76	14.31	12.10	13.59	20.17

Idorsia Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Idorsia (OTCPK:IDRSF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Idorsia Marketable Securities Related Terms

Thank you for viewing the detailed overview of Idorsia's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Idorsia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (OTCPK:IDRSF) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

IDIAz:UK 0RQE:UK IDIA:Switzerland

Address

Hegenheimermattweg 91, Allschwil, CHE, 4123

Website

https://www.idorsia.com

Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.